From Pharma To Telecom To Data Analytics, Piramal Surprises Again - To Buy Decision Resources For $635 Mln
This article was originally published in PharmAsia News
India’s takeover tycoon looks at information arbitrage.
You may also be interested in...
Piramal Profits As It Sheds DRG To Clarivate For $950m
An experienced hand at M&A, Ajay Piramal has done it again – this time selling Decision Resources Group to Clarivate Analytics for $950m. Apart from $900m in cash, Piramal Enterprises will get a stake in Clarivate while the latter expects the acquisition to be earnings-accretive in 2020.
Abbott's Piramal Acquisition Is $3.72 Billion Push In Emerging Markets With Established Products
NEW DELHI - Abbott is all set to become India's largest pharmaceutical company after it announced a $3.72 billion deal to acquire the domestic formulations business of Mumbai-based Piramal Healthcare, ending months of speculation on which multinational would secure India's fourth-largest pharma compan
Indian Investors Turn Cautious On Compliance Concerns
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.